SEC Form 4 · accession 0001209191-15-080564
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Pellini
Officer — Chief Executive Officer · Director
Period of report
Nov 13, 2015
Accepted (ET)
Nov 17, 2015 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 13, 2015 | P | 9,100 | $16.4346 | A | 174,025 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in this Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.18 to $16.50, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.